Logo image of E.CA

ENTERPRISE GROUP INC (E.CA) Stock Fundamental Analysis

Canada - TSX:E - CA29373A3038 - Common Stock

1.43 CAD
-0.01 (-0.69%)
Last: 9/18/2025, 7:00:00 PM
Fundamental Rating

4

E gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 12 industry peers in the Trading Companies & Distributors industry. Both the profitability and the financial health of E get a neutral evaluation. Nothing too spectacular is happening here. E is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year E was profitable.
E had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: E reported negative net income in multiple years.
Each year in the past 5 years E had a positive operating cash flow.
E.CA Yearly Net Income VS EBIT VS OCF VS FCFE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

E has a Return On Assets of 3.38%. This is comparable to the rest of the industry: E outperforms 50.00% of its industry peers.
With a Return On Equity value of 4.12%, E is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
E has a Return On Invested Capital of 4.29%. This is in the lower half of the industry: E underperforms 75.00% of its industry peers.
E had an Average Return On Invested Capital over the past 3 years of 5.80%. This is below the industry average of 7.81%.
Industry RankSector Rank
ROA 3.38%
ROE 4.12%
ROIC 4.29%
ROA(3y)5.48%
ROA(5y)0.43%
ROE(3y)9.07%
ROE(5y)1.09%
ROIC(3y)5.8%
ROIC(5y)N/A
E.CA Yearly ROA, ROE, ROICE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 10.81%, E belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
E has a better Operating Margin (18.26%) than 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 42.39%, E belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
In the last couple of years the Gross Margin of E has grown nicely.
Industry RankSector Rank
OM 18.26%
PM (TTM) 10.81%
GM 42.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.26%
GM growth 5Y11.71%
E.CA Yearly Profit, Operating, Gross MarginsE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so E is destroying value.
Compared to 1 year ago, E has more shares outstanding
Compared to 5 years ago, E has more shares outstanding
E has a better debt/assets ratio than last year.
E.CA Yearly Shares OutstandingE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
E.CA Yearly Total Debt VS Total AssetsE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

E has an Altman-Z score of 3.73. This indicates that E is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.73, E perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that E is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.09, E belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 3.73
ROIC/WACC0.46
WACC9.43%
E.CA Yearly LT Debt VS Equity VS FCFE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

E has a Current Ratio of 4.95. This indicates that E is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of E (4.95) is better than 100.00% of its industry peers.
A Quick Ratio of 4.87 indicates that E has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.87, E belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.95
Quick Ratio 4.87
E.CA Yearly Current Assets VS Current LiabilitesE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

E shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.67%.
Looking at the last year, E shows a very strong growth in Revenue. The Revenue has grown by 128.49%.
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)128.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.86%

3.2 Future

The Earnings Per Share is expected to decrease by -38.20% on average over the next years. This is quite bad
The Revenue is expected to grow by 23.28% on average over the next years. This is a very strong growth
EPS Next Y-127.2%
EPS Next 2Y-55.34%
EPS Next 3Y-38.2%
EPS Next 5YN/A
Revenue Next Year-14.28%
Revenue Next 2Y12.02%
Revenue Next 3Y23.28%
Revenue Next 5YN/A

3.3 Evolution

E.CA Yearly Revenue VS EstimatesE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M
E.CA Yearly EPS VS EstimatesE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2027 0 0.1 0.2

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 71.50 indicates a quite expensive valuation of E.
75.00% of the companies in the same industry are cheaper than E, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of E to the average of the S&P500 Index (27.41), we can say E is valued expensively.
E is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 71.5
Fwd PE N/A
E.CA Price Earnings VS Forward Price EarningsE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

E's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.05
E.CA Per share dataE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as E's earnings are expected to decrease with -38.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.34%
EPS Next 3Y-38.2%

0

5. Dividend

5.1 Amount

No dividends for E!.
Industry RankSector Rank
Dividend Yield N/A

ENTERPRISE GROUP INC

TSX:E (9/18/2025, 7:00:00 PM)

1.43

-0.01 (-0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners11.44%
Inst Owner ChangeN/A
Ins Owners24.83%
Ins Owner ChangeN/A
Market Cap110.87M
Analysts82
Price Target2.29 (60.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.38%
Min EPS beat(2)-60.78%
Max EPS beat(2)-15.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.9%
Min Revenue beat(2)-21.85%
Max Revenue beat(2)-7.95%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.07%
PT rev (3m)-7.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-22.48%
EPS NY rev (3m)-22.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-9.24%
Revenue NY rev (3m)-8.8%
Valuation
Industry RankSector Rank
PE 71.5
Fwd PE N/A
P/S 3.4
P/FCF N/A
P/OCF 9.64
P/B 1.29
P/tB 1.3
EV/EBITDA 10.05
EPS(TTM)0.02
EY1.4%
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.15
OCFY10.38%
SpS0.42
BVpS1.1
TBVpS1.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 4.12%
ROCE 5.96%
ROIC 4.29%
ROICexc 4.89%
ROICexgc 4.91%
OM 18.26%
PM (TTM) 10.81%
GM 42.39%
FCFM N/A
ROA(3y)5.48%
ROA(5y)0.43%
ROE(3y)9.07%
ROE(5y)1.09%
ROIC(3y)5.8%
ROIC(5y)N/A
ROICexc(3y)6.57%
ROICexc(5y)N/A
ROICexgc(3y)6.62%
ROICexgc(5y)N/A
ROCE(3y)8.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.26%
GM growth 5Y11.71%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA 0.73
Cap/Depr 373.7%
Cap/Sales 55.8%
Interest Coverage 2.35
Cash Conversion 106.15%
Profit Quality N/A
Current Ratio 4.95
Quick Ratio 4.87
Altman-Z 3.73
F-Score5
WACC9.43%
ROIC/WACC0.46
Cap/Depr(3y)249.08%
Cap/Depr(5y)167.2%
Cap/Sales(3y)38.21%
Cap/Sales(5y)28.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-127.2%
EPS Next 2Y-55.34%
EPS Next 3Y-38.2%
EPS Next 5YN/A
Revenue 1Y (TTM)128.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.86%
Revenue Next Year-14.28%
Revenue Next 2Y12.02%
Revenue Next 3Y23.28%
Revenue Next 5YN/A
EBIT growth 1Y-37.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.04%
EBIT Next 3Y49.84%
EBIT Next 5YN/A
FCF growth 1Y-497.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.3%
OCF growth 3Y51.34%
OCF growth 5Y27.44%